- Morphic Therapeutic (NASDAQ:MORF) has announced that Simon Cooper, M.B.B.S., has joined the Co. as Chief Medical Officer.
- Dr. Cooper most recently served as Chief Medical Officer of Keros Therapeutics.
- “Simon brings clinical development expertise stemming from leadership roles across the entire spectrum of clinical development from first-in-human studies through FDA submissions and approvals of highly successful therapeutics," said Praveen Tipirneni, CEO.
Morphic appoints Simon Cooper as CMO
Recommended For You
More Trending News
About MORF Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| MORF | - | - |
| Morphic Holding, Inc. | ||